» Articles » PMID: 16259872

Pathological Distribution of Positive Lymph Nodes in Patients with Clinically and Radiologically N0 Oropharyngeal Carcinoma: Implications for IMRT Treatment Planning

Overview
Journal Cancer J
Specialty Oncology
Date 2005 Nov 2
PMID 16259872
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We identified involved lymph node groups in patients with oropharyngeal carcinoma and radiologically N0 disease, aiming to define the clinical target volume, and to assess the negative predictive value of CT neck and correlate it to the tumor site, stage, and grade.

Methods And Materials: Between 1988 and 2000, we evaluated 53 patients who satisfied all of the following criteria: 1) oropharyngeal carcinoma diagnosis; 2) NO stage based on CT; 3) no prior treatment; and 4) primary surgical resection including ipsi-lateral neck dissection. The pathology reports were reviewed to identify the exact site of lymph node involvement.

Results: Twenty patients (37.7%) were found to have pathologically positive lymph nodes, yielding a negative predictive value of 62.3% for CT neck. Node levels II, III, and IV were the most commonly involved (26%, 17%, and 11% of all patients, respectively). Fifty percent of patients with T3 and T4 tumors had positive lymph nodes versus 20% of patients with T1 and T2 (P = 0.036). Tumor grade and site were insignificant (P > 0.05).

Discussion: Ipsilateral neck levels II-IV should be included during elective nodal irradiation in patients with N0-stage oropharyngeal carcinoma, regardless of the primary tumor site, stage, and grade.

Citing Articles

Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI.

DUrso P, Farneti A, Marucci L, Marzi S, Piludu F, Vidiri A Cancers (Basel). 2022; 14(10).

PMID: 35626084 PMC: 9139324. DOI: 10.3390/cancers14102477.


Metastatic disease in head & neck oncology.

Pisani P, Airoldi M, Allais A, Aluffi Valletti P, Battista M, Benazzo M Acta Otorhinolaryngol Ital. 2020; 40(SUPPL. 1):S1-S86.

PMID: 32469009 PMC: 7263073. DOI: 10.14639/0392-100X-suppl.1-40-2020.